Recordati SpA

Recordati SpA REC

Dividend Summary

The next Recordati SpA dividend is expected to go ex in 4 months and to be paid in 4 months.
The previous Recordati SpA dividend was 55¢ and it went ex 2 months ago and it was paid 2 months ago.
There are typically 2 dividends per year (excluding specials), and the dividend cover is approximately 1.7.

Latest Dividends
Summary Previous dividend Next dividend
Status Paid Forecast
Type Final Interim
Per share 55¢ Sign Up Required
Declaration date 23 Mar 2021 (Tue) 27 Oct 2021 (Wed)
Ex-div date 24 May 2021 (Mon) 15 Nov 2021 (Mon)
Pay date 26 May 2021 (Wed) 24 Nov 2021 (Wed)

Enter the number of Recordati SpA shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
95%
Our premium tools have predicted Recordati SpA with 95% accuracy.
Dividend Yield Today
2.1%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for Recordati SpA
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
Forecast Final 06 Mar 2026 13 Apr 2026 15 Apr 2026 EUR Sign up
Forecast Interim 22 Oct 2025 17 Nov 2025 19 Nov 2025 EUR Sign up
Forecast Final 07 Mar 2025 14 Apr 2025 16 Apr 2025 EUR Sign up
Forecast Interim 23 Oct 2024 18 Nov 2024 20 Nov 2024 EUR Sign up
Forecast Final 08 Mar 2024 15 Apr 2024 17 Apr 2024 EUR Sign up
Forecast Interim 25 Oct 2023 20 Nov 2023 22 Nov 2023 EUR Sign up
Forecast Final 10 Mar 2023 17 Apr 2023 19 Apr 2023 EUR Sign up
Forecast Interim 26 Oct 2022 21 Nov 2022 23 Nov 2022 EUR Sign up
Forecast Final 11 Mar 2022 18 Apr 2022 20 Apr 2022 EUR Sign up
Forecast Interim 27 Oct 2021 15 Nov 2021 24 Nov 2021 EUR Sign up
Paid Final 23 Mar 2021 24 May 2021 26 May 2021 EUR 53¢ 55¢ 😃
Paid Interim 19 Nov 2020 23 Nov 2020 25 Nov 2020 EUR 49¢ 50¢ 😃
Paid Final 18 Mar 2020 18 May 2020 20 May 2020 EUR 49¢ 52¢ 😊
Paid Interim 04 Nov 2019 18 Nov 2019 20 Nov 2019 EUR 48¢ 48¢ 😄
Paid Final 01 Mar 2019 23 Apr 2019 25 Apr 2019 EUR 47¢
Paid Interim 31 Oct 2018 19 Nov 2018 21 Nov 2018 EUR 45¢
Paid Final 16 Mar 2018 23 Apr 2018 25 Apr 2018 EUR 43¢
Paid Interim 27 Oct 2017 20 Nov 2017 22 Nov 2017 EUR 42¢
Paid Final 01 Mar 2017 24 Apr 2017 26 Apr 2017 EUR 35¢
Paid Interim 27 Oct 2016 21 Nov 2016 23 Nov 2016 EUR 35¢
Paid Final 10 Mar 2016 18 Apr 2016 20 Apr 2016 EUR 30¢
Paid Interim 09 Nov 2015 11 Nov 2015 EUR 30¢
Paid Final 04 Mar 2015 20 Apr 2015 22 Apr 2015 EUR 24¢
Paid Interim 29 Oct 2014 17 Nov 2014 19 Nov 2014 EUR 26¢
Paid Final 06 Mar 2014 28 Apr 2014 02 May 2014 EUR 11¢
Paid Interim 20 Dec 2012 18 Nov 2013 21 Nov 2013 EUR 22¢
Paid Final 20 Dec 2012 22 Apr 2013 25 Apr 2013 EUR 10¢
Paid Interim 19 Nov 2012 22 Nov 2012 EUR 20¢
Year Amount Change
2006 0.0¢
2007 0.0¢
0%
2008 0.0¢
0%
2009 0.0¢
0%
2010 0.0¢
0%
2011 0.0¢
0%
2012 30.0¢
100%
2013 33.0¢
10.0%
2014 50.0¢
51.5%
2015 60.0¢
20.0%
2016 70.0¢
16.7%
2017 85.0¢
21.4%
2018 92.0¢
8.2%
2019 100.0¢
8.7%
2020 105.0¢
5.0%
2021 Sign Up Required
2022 Sign Up Required
2023 Sign Up Required
2024 Sign Up Required
2025 Sign Up Required

Recordati SpA Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
2.1%
Optimized Yield
Sign Up Required
52 Week High
4.0% on 16 May 2021
52 Week Low
2.3% on 12 July 2021
Next Ex-Div-Date Countdown
Sign Up Required

About Recordati SpA

Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The Company owns and operates through Natural Point srl also in the food supplement sector.

Sector
Pharmaceuticals & Biotechnology
Country
Italy
Share Price
€52.18 (yesterday's closing price)
Shares in Issue
209 million
Market Cap
€10.9bn
Dividend Cover
How many times is the dividend covered by company income. A cover of 1 means all income is paid out in dividends
1.7
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
9
Market Indices
STOXX600
No articles found